Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] NLMUID: 7513617"" wg kryterium: JN


Tytuł :
In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
Autorzy :
Peiffer-Smadja N; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, Assistance-Publique Hôpitaux de Paris, Paris, France.; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.
Guillotel E; CHU de Rennes, Service de Bactériologie-Hygiène hospitalière, Rennes, France.
Luque-Paz D; CHU de Rennes, Service de Bactériologie-Hygiène hospitalière, Rennes, France.
Maataoui N; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Laboratoire de Bactériologie, Hôpital Bichat-Claude Bernard, Assistance-Publique Hôpitaux de Paris, Paris, France.
Lescure FX; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, Assistance-Publique Hôpitaux de Paris, Paris, France.; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.
Cattoir V; CHU de Rennes, Service de Bactériologie-Hygiène hospitalière, Rennes, France.; CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), Rennes, France.; Unité Inserm U1230, Université de Rennes 1, Rennes, France.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3511-3514.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amoxicillin/*pharmacology
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Enterococcus faecalis/*drug effects
Drug Synergism ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł :
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
Autorzy :
Antonelli A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Giani T; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
Coppi M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Di Pilato V; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Arena F; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Colavecchio OL; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Conte V; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Santerre Henriksen A; Basilea Pharmaceutica International Ltd, Basel, Switzerland.
Rossolini GM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
Pokaż więcej
Corporate Authors :
MRSA-HAP Study Group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3453-3461.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Cross Infection/*epidemiology
Pneumonia, Bacterial/*epidemiology
Staphylococcal Infections/*epidemiology
Anti-Bacterial Agents/therapeutic use ; Bacterial Typing Techniques ; Cephalosporins/therapeutic use ; Cross Infection/microbiology ; DNA, Bacterial/genetics ; Humans ; Italy/epidemiology ; Methicillin-Resistant Staphylococcus aureus/drug effects ; Methicillin-Resistant Staphylococcus aureus/genetics ; Microbial Sensitivity Tests ; Molecular Epidemiology ; Multilocus Sequence Typing ; Prevalence ; Public Health Surveillance ; Staphylococcal Infections/microbiology ; Staphylococcus aureus/drug effects ; Staphylococcus aureus/genetics ; Virulence/genetics ; Whole Genome Sequencing
Czasopismo naukowe
Tytuł :
Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar.
Autorzy :
Sid Ahmed MA; Microbiology Division, Hamad Medical Corporation, Doha, Qatar.; The Life Science Centre, School of Science and Technology, Örebro University, Örebro, Sweden.
Abdel Hadi H; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Hassan AAI; Division of General Medicine, Wayne State University, Detroit, MI, USA.
Abu Jarir S; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Al-Maslamani MA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Eltai NO; Biomedical Research Center, Qatar University, Doha, Qatar.
Dousa KM; University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Hujer AM; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Louis Stokes Cleveland, Department of Veterans Affairs Medical Center, Cleveland, OH, USA.
Sultan AA; Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar.
Soderquist B; The Life Science Centre, School of Science and Technology, Örebro University, Örebro, Sweden.
Bonomo RA; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Louis Stokes Cleveland, Department of Veterans Affairs Medical Center, Cleveland, OH, USA.; Departments of Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; The CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA.
Ibrahim EB; Microbiology Division, Hamad Medical Corporation, Doha, Qatar.
Jass J; The Life Science Centre, School of Science and Technology, Örebro University, Örebro, Sweden.
Omrani AS; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3497-3504.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Multiple, Bacterial*
Anti-Bacterial Agents/*pharmacology
Azabicyclo Compounds/*pharmacology
Ceftazidime/*pharmacology
Cephalosporins/*pharmacology
Pseudomonas aeruginosa/*drug effects
Tazobactam/*pharmacology
Drug Combinations ; Humans ; Microbial Sensitivity Tests ; Prospective Studies ; Pseudomonas Infections/microbiology ; Pseudomonas aeruginosa/genetics ; Qatar ; Whole Genome Sequencing
Czasopismo naukowe
Tytuł :
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.
Autorzy :
Trecarichi EM; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Quirino A; Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Scaglione V; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Longhini F; Unit of Intensive Care, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Garofalo E; Unit of Intensive Care, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Bruni A; Unit of Intensive Care, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Biamonte E; Unit of Intensive Care, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Lionello R; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Serapide F; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Mazzitelli M; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Marascio N; Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Matera G; Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Liberto MC; Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Navalesi P; Unit of Intensive Care, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Torti C; Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
Pokaż więcej
Corporate Authors :
IMAGES Group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Nov 01; Vol. 74 (11), pp. 3399-3401.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Drug Resistance, Multiple, Bacterial*
Acinetobacter Infections/*drug therapy
Anti-Bacterial Agents/*therapeutic use
Cephalosporins/*therapeutic use
Klebsiella Infections/*drug therapy
Acinetobacter Infections/blood ; Acinetobacter baumannii/drug effects ; Adult ; Compassionate Use Trials ; Critical Illness/therapy ; Humans ; Influenza, Human/complications ; Influenza, Human/microbiology ; Klebsiella Infections/blood ; Klebsiella pneumoniae/drug effects ; Microbial Sensitivity Tests ; Pneumonia/complications ; Pneumonia/virology ; Treatment Outcome
Raport
Tytuł :
Polyclonal gut colonization with extended-spectrum cephalosporin- and/or colistin-resistant Enterobacteriaceae: a normal status for hotel employees on the island of Zanzibar, Tanzania.
Autorzy :
Büdel T; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Kuenzli E; Department of Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Clément M; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Bernasconi OJ; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Fehr J; Department of Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Mohammed AH; Zanzibar Food and Drug Agency, Zanzibar, Tanzania.
Hassan NK; Zanzibar Food and Drug Agency, Zanzibar, Tanzania.
Zinsstag J; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Hatz C; Department of Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Endimiani A; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 2880-2890.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Bacterial*
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Colistin/*pharmacology
Enterobacteriaceae/*drug effects
Enterobacteriaceae Infections/*microbiology
Rectum/*microbiology
Adult ; Aged ; Aged, 80 and over ; Bacteriological Techniques ; Carrier State/epidemiology ; Carrier State/microbiology ; Enterobacteriaceae/classification ; Enterobacteriaceae/isolation & purification ; Enterobacteriaceae Infections/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction ; Prevalence ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Tanzania/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
Autorzy :
Hurley JC; Melbourne Medical School, University of Melbourne, Internal Medicine Service, Ballarat Health Services, Ballarat, Victoria, Australia.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 3087-3094.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Bacteremia/*drug therapy
Cephalosporins/*therapeutic use
Enterococcus/*drug effects
Antibiotic Prophylaxis/methods ; Cross Infection/drug therapy ; Cross Infection/microbiology ; Decontamination/methods ; Gastrointestinal Tract/microbiology ; Humans ; Incidence ; Intensive Care Units ; Oropharynx/drug effects ; Respiration, Artificial/methods ; Risk Factors
Czasopismo naukowe
Tytuł :
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
Autorzy :
Duss FR; Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland.
Garcia de la Mària C; Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Croxatto A; Institute of Microbiology, University Hospital and University of Lausanne, Lausanne, Switzerland.
Giulieri S; Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland.
Lamoth F; Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Microbiology, University Hospital and University of Lausanne, Lausanne, Switzerland.
Manuel O; Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland.; Transplantation Center, University Hospital and University of Lausanne, Lausanne, Switzerland.
Miró JM; Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Sep 01; Vol. 74 (9), pp. 2626-2630.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Cephalosporins/*therapeutic use
Daptomycin/*therapeutic use
Endocarditis/*drug therapy
Methicillin-Resistant Staphylococcus aureus/*drug effects
Staphylococcal Infections/*drug therapy
Aged, 80 and over ; Community-Acquired Infections/diagnosis ; Community-Acquired Infections/drug therapy ; Community-Acquired Infections/microbiology ; Drug Synergism ; Endocarditis/diagnosis ; Endocarditis/microbiology ; Fosfomycin/pharmacology ; Humans ; Male ; Microbial Sensitivity Tests ; Staphylococcal Infections/diagnosis ; Staphylococcal Infections/microbiology
Czasopismo naukowe
Tytuł :
Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects.
Autorzy :
Katsube T; Clinical Pharmacology & Pharmacokinetics, Shionogi & Co., Ltd, Osaka, Japan.
Saisho Y; Medical Affairs Department, Shionogi & Co., Ltd, Osaka, Japan.
Shimada J; St Marianna University School of Medicine, Kawasaki, Japan.
Furuie H; Osaka Pharmacology Clinical Research Hospital, Osaka, Japan.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 1971-1974.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cephalosporins/*pharmacokinetics
Lung/*drug effects
Siderophores/*pharmacokinetics
Adult ; Drug Monitoring ; Gram-Negative Bacteria/drug effects ; Healthy Volunteers ; Humans ; Male ; Young Adult
Czasopismo naukowe
Tytuł :
ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa.
Autorzy :
Ortiz de la Rosa JM; Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.
Nordmann P; Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.; Swiss National Reference Centre for Emerging Antibiotic Resistance, Fribourg, Switzerland.; INSERM European Unit (LEA), IAME, Paris, France.; University of Lausanne and University Hospital Centre, Lausanne, Switzerland.
Poirel L; Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.; Swiss National Reference Centre for Emerging Antibiotic Resistance, Fribourg, Switzerland.; INSERM European Unit (LEA), IAME, Paris, France.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 1934-1939.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Multiple, Bacterial*
Azabicyclo Compounds/*pharmacology
Ceftazidime/*pharmacology
Cephalosporins/*pharmacology
Escherichia coli/*drug effects
Escherichia coli/*genetics
Pseudomonas aeruginosa/*drug effects
Pseudomonas aeruginosa/*genetics
Tazobactam/*pharmacology
beta-Lactamases/*genetics
Drug Combinations ; Escherichia coli Infections/drug therapy ; Escherichia coli Infections/microbiology ; Humans ; Microbial Sensitivity Tests ; Pseudomonas Infections/drug therapy ; Pseudomonas Infections/microbiology ; beta-Lactamase Inhibitors/pharmacology ; beta-Lactamase Inhibitors/therapeutic use ; beta-Lactamases/biosynthesis
Czasopismo naukowe
Tytuł :
Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.
Autorzy :
Gianecini RA; National Reference Laboratory of Sexually Transmitted Diseases, National Institute of Infectious Diseases - ANLIS 'Dr Carlos G. Malbrán', Ciudad Autónoma de Buenos Aires, Argentina.
Golparian D; WHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Zittermann S; Public Health Ontario Laboratories, Toronto, Canada.
Litvik A; Rawson Infectious Diseases Hospital, Córdoba, Argentina.
Gonzalez S; Rawson Infectious Diseases Hospital, Córdoba, Argentina.
Oviedo C; National Reference Laboratory of Sexually Transmitted Diseases, National Institute of Infectious Diseases - ANLIS 'Dr Carlos G. Malbrán', Ciudad Autónoma de Buenos Aires, Argentina.
Melano RG; Public Health Ontario Laboratories, Toronto, Canada.
Unemo M; WHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Galarza P; National Reference Laboratory of Sexually Transmitted Diseases, National Institute of Infectious Diseases - ANLIS 'Dr Carlos G. Malbrán', Ciudad Autónoma de Buenos Aires, Argentina.
Pokaż więcej
Corporate Authors :
Gonococcal Antimicrobial Susceptibility Surveillance Programme-Argentina (GASSP-AR) Working Group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jun 01; Vol. 74 (6), pp. 1551-1559.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Drug Resistance, Multiple, Bacterial/*genetics
Gonorrhea/*epidemiology
Gonorrhea/*microbiology
Neisseria gonorrhoeae/*drug effects
Adolescent ; Adult ; Argentina/epidemiology ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Female ; Genome, Bacterial ; Humans ; Male ; Microbial Sensitivity Tests ; Molecular Epidemiology ; Phylogeny ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h.
Autorzy :
Cheng K; Pfizer, Sandwich, UK.
Pypstra R; Pfizer, New York, NY, USA.
Yan JL; Pfizer, New York, NY, USA.
Hammond J; Pfizer, Collegeville, PA, USA.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Apr 01; Vol. 74 (4), pp. 1086-1091.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Anti-Bacterial Agents/*administration & dosage
Cephalosporins/*administration & dosage
Staphylococcal Infections/*drug therapy
Staphylococcal Infections/*microbiology
Staphylococcus aureus/*drug effects
Anti-Bacterial Agents/adverse effects ; Cephalosporins/adverse effects ; Drug Administration Schedule ; Female ; Humans ; Male ; Microbial Sensitivity Tests ; Staphylococcal Infections/diagnosis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain.
Autorzy :
Chauzy A; Université de Poitiers, INSERM U1070, CHU Poitiers, Poitiers, France.
Nadji A; Neuroréanimation, Hôpital du Bocage, CHU Dijon, Dijon, France.
Combes JC; Neuroréanimation, Hôpital du Bocage, CHU Dijon, Dijon, France.
Defrance N; Neuroréanimation, Hôpital du Bocage, CHU Dijon, Dijon, France.
Bouhemad B; Neuroréanimation, Hôpital du Bocage, CHU Dijon, Dijon, France.
Couet W; Université de Poitiers, INSERM U1070, CHU Poitiers, Poitiers, France.
Chavanet P; Département d'Infectiologie, CHU and INSERM CIC1432, Université de Bourgogne, Dijon, France.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Mar 01; Vol. 74 (3), pp. 675-681.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drainage*
Neurosurgical Procedures*/adverse effects
Neurosurgical Procedures*/methods
Anti-Bacterial Agents/*pharmacokinetics
Cephalosporins/*pharmacokinetics
Cerebral Ventricles/*surgery
Cerebrospinal Fluid/*metabolism
Adolescent ; Adult ; Aged ; Anti-Bacterial Agents/administration & dosage ; Cephalosporins/administration & dosage ; Cerebral Ventriculitis/drug therapy ; Cerebral Ventriculitis/etiology ; Cerebral Ventriculitis/prevention & control ; Chromatography, Liquid ; Female ; Humans ; Infusions, Intravenous ; Intensive Care Units ; Male ; Meningitis, Bacterial/drug therapy ; Meningitis, Bacterial/etiology ; Meningitis, Bacterial/prevention & control ; Middle Aged ; Models, Theoretical ; Postoperative Complications/drug therapy ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Tandem Mass Spectrometry ; Young Adult
Czasopismo naukowe
Tytuł :
In vitro susceptibility of Salmonella enterica serovar Typhi to ceftolozane/tazobactam.
Autorzy :
Chan E; Department of Microbiology, The University of Hong Kong, Hong Kong, China.
Wu AKL; Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Tse CWS; Department of Pathology, Kwong Wah Hospital, Hong Kong, China.
Lau SKP; Department of Microbiology, The University of Hong Kong, Hong Kong, China.; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong, China.
Woo PCY; Department of Microbiology, The University of Hong Kong, Hong Kong, China.; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong, China.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Feb 01; Vol. 74 (2), pp. 528-530.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Cephalosporins/*pharmacology
Salmonella typhi/*drug effects
Tazobactam/*pharmacology
Feces/microbiology ; Humans ; Microbial Sensitivity Tests ; Typhoid Fever/microbiology
Raport
Tytuł :
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
Autorzy :
Das S; AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK.
Li J; AstraZeneca, 35 Gatehouse Drive, Waltham, MA, USA.
Iaconis J; AstraZeneca, 35 Gatehouse Drive, Waltham, MA, USA.
Zhou D; AstraZeneca, 35 Gatehouse Drive, Waltham, MA, USA.
Stone GG; AstraZeneca, 35 Gatehouse Drive, Waltham, MA, USA.
Yan JL; Pfizer, 235 E 42nd St, New York, NY, USA.
Melnick D; Allergan Inc., 5 Giralda Farms, Madison, NJ, USA.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Feb 01; Vol. 74 (2), pp. 425-431.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*pharmacokinetics
Cephalosporins/*pharmacokinetics
Soft Tissue Infections/*drug therapy
Soft Tissue Infections/*microbiology
Staphylococcal Infections/*drug therapy
Staphylococcal Skin Infections/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Cephalosporins/therapeutic use ; Child ; Clinical Trials as Topic ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Staphylococcal Infections/complications ; Staphylococcus aureus/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.
Autorzy :
So W; Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, USA.
Shurko J; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.; School of Medicine, The University of Texas Health San Antonio, San Antonio, TX, USA.
Galega R; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.; School of Medicine, The University of Texas Health San Antonio, San Antonio, TX, USA.
Quilitz R; Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, USA.
Greene JN; Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, USA.
Lee GC; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.; School of Medicine, The University of Texas Health San Antonio, San Antonio, TX, USA.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jan 01; Vol. 74 (1), pp. 269-271.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Drug Resistance, Bacterial*
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Pseudomonas Infections/*microbiology
Pseudomonas aeruginosa/*drug effects
Tazobactam/*pharmacology
Tobramycin/*therapeutic use
beta-Lactamase Inhibitors/*pharmacology
Anti-Bacterial Agents/therapeutic use ; Drug Synergism ; Humans ; Microbial Sensitivity Tests ; Pseudomonas Infections/drug therapy ; Pseudomonas aeruginosa/isolation & purification ; Treatment Outcome
Raport
Tytuł :
Clostridioides difficile incidence related to in-hospital cephalosporin use: a tale of two highly comparable hospitals.
Autorzy :
Karp J; Department of Infectious Diseases, Skaraborg Hospital, Lövängsvägen, Skövde, Sweden.; Center for Antibiotic Resistance Research (CARe), Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Edman-Wallér J; Center for Antibiotic Resistance Research (CARe), Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Hospital Infection Control, Södra Älvsborg Hospital, Brämhultsvägen, Borås, Sweden.
Toepfer M; Clinical Microbiology, Unilabs AB, Rådhusgatan 6, Skövde, Sweden.
Lundqvist A; Department of Infectious Diseases, Södra Älvsborg Hospital, Brämhultsvägen 53, Borås, Sweden.
Jacobsson G; Department of Infectious Diseases, Skaraborg Hospital, Lövängsvägen, Skövde, Sweden.; Center for Antibiotic Resistance Research (CARe), Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jan 01; Vol. 74 (1), pp. 182-189.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*adverse effects
Anti-Bacterial Agents/*therapeutic use
Cephalosporins/*adverse effects
Cephalosporins/*therapeutic use
Clostridioides difficile/*isolation & purification
Clostridium Infections/*epidemiology
Cross Infection/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Scandinavian and Nordic Countries/epidemiology
Czasopismo naukowe
Tytuł :
Extended-spectrum cephalosporin-resistant Escherichia coli isolated from chickens and chicken meat in Brazil is associated with rare and complex resistance plasmids and pandemic ST lineages.
Autorzy :
Casella T; Instituto de Biociências, Letras e Ciências Exatas, Universidade Estadual Paulista 'Júlio de Mesquita Filho', São José do Rio Preto, Brazil.; Unité d'Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.; Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.; Hospital de Base de São José do Rio Preto, São José do Rio Preto, Brazil.
Haenni M; Unité d'Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.
Madela NK; Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.
Andrade LK; Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.
Pradela LK; Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.
Andrade LN; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Darini ALDC; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Madec JY; Unité d'Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.
Nogueira MCL; Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2018 Dec 01; Vol. 73 (12), pp. 3293-3297.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Bacterial*
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Escherichia coli/*drug effects
Plasmids/*genetics
Poultry Products/*microbiology
Animals ; Bacterial Typing Techniques ; Brazil/epidemiology ; Chickens/microbiology ; Cloaca/microbiology ; Escherichia coli/isolation & purification ; Escherichia coli/pathogenicity ; Escherichia coli Infections/epidemiology ; Escherichia coli Infections/veterinary ; Genetic Variation ; Microbial Sensitivity Tests ; Multilocus Sequence Typing ; Phylogeny ; Poultry/microbiology ; Virulence Factors/genetics ; beta-Lactamases/genetics
Czasopismo naukowe
Tytuł :
Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Autorzy :
Ito A; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Nishikawa T; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Ota M; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Ito-Horiyama T; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Ishibashi N; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Sato T; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Tsuji M; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Yamano Y; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2018 Nov 01; Vol. 73 (11), pp. 3049-3052.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Bacterial Proteins/*genetics
Cephalosporins/*pharmacology
Enterobacter cloacae/*drug effects
Enterobacter cloacae/*genetics
Pseudomonas aeruginosa/*drug effects
beta-Lactamases/*genetics
Carbapenems/pharmacology ; Chromosomes, Bacterial ; Drug Resistance, Multiple, Bacterial ; Enterobacter cloacae/enzymology ; Imipenem/pharmacology ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa/enzymology ; Pseudomonas aeruginosa/genetics
Czasopismo naukowe
Tytuł :
Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.
Autorzy :
Noel AR; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
Bowker KE; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
Attwood M; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
MacGowan AP; Bristol Centre for Antimicrobial Research & Evaluation, North Bristol NHS Trust, Department of Infection Sciences, Pathology Sciences Building Phase 2, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2018 Sep 01; Vol. 73 (9), pp. 2411-2417.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amikacin/*administration & dosage
Anti-Bacterial Agents/*administration & dosage
Cephalosporins/*administration & dosage
Gram-Negative Bacteria/*drug effects
Gram-Negative Bacterial Infections/*drug therapy
Tazobactam/*administration & dosage
beta-Lactamase Inhibitors/*administration & dosage
Amikacin/pharmacokinetics ; Amikacin/pharmacology ; Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/pharmacology ; Bacterial Load ; Cephalosporins/pharmacokinetics ; Cephalosporins/pharmacology ; Drug Therapy, Combination/methods ; Gram-Negative Bacteria/growth & development ; Meropenem/administration & dosage ; Meropenem/pharmacokinetics ; Meropenem/pharmacology ; Microbial Sensitivity Tests ; Microbial Viability/drug effects ; Models, Theoretical ; Tazobactam/pharmacokinetics ; Tazobactam/pharmacology ; beta-Lactamase Inhibitors/pharmacokinetics ; beta-Lactamase Inhibitors/pharmacology
Czasopismo naukowe
Tytuł :
In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
Autorzy :
Thieme L; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Klinger-Strobel M; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Hartung A; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Stein C; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.; InfectoGnostics Forschungscampus Jena e.V., Zentrum für Angewandte Forschung, Jena, Germany.
Makarewicz O; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.; InfectoGnostics Forschungscampus Jena e.V., Zentrum für Angewandte Forschung, Jena, Germany.
Pletz MW; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.; InfectoGnostics Forschungscampus Jena e.V., Zentrum für Angewandte Forschung, Jena, Germany.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2018 Jun 01; Vol. 73 (6), pp. 1553-1561.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Ampicillin/*pharmacology
Anti-Bacterial Agents/*pharmacology
Biofilms/*drug effects
Ceftriaxone/*pharmacology
Cephalosporins/*pharmacology
Enterococcus faecalis/*drug effects
Gentamicins/*pharmacology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Drug Synergism ; Endocarditis, Bacterial/drug therapy ; Female ; Gram-Positive Bacterial Infections/drug therapy ; Gram-Positive Bacterial Infections/microbiology ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies